Close
  Indian J Med Microbiol
 

Figure 1: (a) In 2007, preoperative staging computed tomography of the abdomen and pelvis showed a heterogeneous prostate gland without evidence of extraprostatic extension or pelvic lymph node enlargement. (b) In early 2016, after failing salvage radiotherapy, prostate-specific antigen reached 5ng/ml, which led to repeat imaging. Computed tomography detected a new left lower lobe lung nodule but no evidence of disease in the pelvis. The nodule was biopsied and proved to be metastatic prostatic adenocarcinoma. 18F-sodium fluoride positron emission tomography/computed tomography and (c) 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography. Verified a solitary, minimally fluoro-2-deoxy-D-glucose-avid, left lower lobe nodule (blue arrows)

Figure 1: (a) In 2007, preoperative staging computed tomography of the abdomen and pelvis showed a heterogeneous prostate gland without evidence of extraprostatic extension or pelvic lymph node enlargement. (b) In early 2016, after failing salvage radiotherapy, prostate-specific antigen reached 5ng/ml, which led to repeat imaging. Computed tomography detected a new left lower lobe lung nodule but no evidence of disease in the pelvis. The nodule was biopsied and proved to be metastatic prostatic adenocarcinoma. <sup>18</sup>F-sodium fluoride positron emission tomography/computed tomography and (c) <sup>18</sup>F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography. Verified a solitary, minimally fluoro-2-deoxy-D-glucose-avid, left lower lobe nodule (blue arrows)